A 59-year-old man with advanced type II diabetes presents to the physician for a 2-week history of urinary incontinence. Physical examination shows a suprapubic mass. Urinary post-void volume is 300 mL. The most appropriate pharmacologic agent for this patient’s condition most likely has which of the following molecular effects?
↓ cAMP
↓ cGMP
↓ Phosphoinositide turnover
↑ cAMP
↑ cGMP
↑ Phosphoinositide turnover
